cholic acid has been researched along with fluorobenzenes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abellán Guillén, A; Cordeiro, MN; Garrido Escudero, A; Morales Helguera, A; Pérez-Garrido, A | 1 |
| Demonte, A; Fassini, PG; Ferreira, ES; Neves, VA; Noda, RW; Silva, MA | 1 |
| Barabanchyk, OV; Kozak, NP; Svintsits'kyĭ, AS | 1 |
3 other study(ies) available for cholic acid and fluorobenzenes
| Article | Year |
|---|---|
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
Topics: beta-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Organic Chemicals; Quantitative Structure-Activity Relationship | 2009 |
Soybean glycinin improves HDL-C and suppresses the effects of rosuvastatin on hypercholesterolemic rats.
Topics: Animals; Atherosclerosis; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholic Acid; Combined Modality Therapy; Dietary Supplements; Fluorobenzenes; Food-Drug Interactions; Globulins; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipoproteins; Liver; Male; Pyrimidines; Rats; Rats, Wistar; Risk Factors; Rosuvastatin Calcium; Soybean Proteins; Sulfonamides; Triglycerides | 2011 |
[CORRECTION OF BILE FLOW CHARACTERISTICS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN COMBINATION WITH HYPERURICEMIA].
Topics: Adult; Allopurinol; Bile; Cholagogues and Choleretics; Cholestasis, Intrahepatic; Cholesterol; Cholic Acid; Deoxycholic Acid; Drug Therapy, Combination; Duodenoscopy; Female; Fluorobenzenes; Humans; Hyperuricemia; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Taurocholic Acid; Uric Acid; Ursodeoxycholic Acid | 2014 |